Fulcrum Therapeutics Inc. (FULC)
NASDAQ · Healthcare
Fulcrum Therapeutics Inc. Shareholder Equity 2020–2025
Fulcrum Therapeutics Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Fulcrum Therapeutics Inc. shareholder equity as of December 31, 2025: 349.0M, a 43.60% increase year-over-year.
- Fulcrum Therapeutics Inc. shareholder equity for 2025 were 349.0M, a 43.60% increase from 2024.
- Fulcrum Therapeutics Inc. shareholder equity for 2024 were 243.0M, a 3.33% increase from 2023.
- Fulcrum Therapeutics Inc. shareholder equity for 2023 were 235.2M, a 18.22% increase from 2022.
- Fulcrum Therapeutics Inc. shareholder equity for 2022 were 198.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Fulcrum Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $349 |
| 2024 | $243 |
| 2023 | $235 |
| 2022 | $199 |
| 2021 | $212 |
| 2020 | $95 |
Fulcrum Therapeutics Inc. Shareholder Equity — FAQ
Fulcrum Therapeutics Inc. (FULC) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FULC's shareholder equity history?
The chart and table above show Fulcrum Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.